Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Bone Metabolism
Drospirenone + ethinyl estradiol oral contraceptive reduces bone turnover
December 16th, 2004
Study results show that an oral contraceptive containing drospirenone and ethinyl estradiol, taken for 6 months, reduced bone turnover in young women. A.M. Paoletti and colleagues, University of Cagliari, Italy, conducted a clinical study in which 28 healthy, eumenorrheic, young, postadolescent women were given an oral contraceptive (OC) containing drospirenone (3 mg) plus ethinyl estradiol (30 mcg) (DRSP+EE) and a control group of 26 women received no treatment. The researchers wanted to see if the contraceptive formulation affected bone metabolism. According to the researchers, the "women did not differ in age, body mass index, waist-to-hip ratio,...
Source: Women's Health Weekly (2004-12-16)
|
